CompletedPhase 3NCT03841357
Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
Studying Juvenile idiopathic arthritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Duke University
- Principal Investigator
- Laura Schanberg, MDDuke University
- Intervention
- Abatacept Injection(drug)
- Enrollment
- 121 enrolled
- Eligibility
- 2-16 years · All sexes
- Timeline
- 2019 – 2025
Study locations (19)
- University of California at San Francisco Medical Center, San Francisco, California, United States
- The Children's Hospital Colorado, Aurora, Colorado, United States
- Shands at the University of Florida, Gainesville, Florida, United States
- Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana, United States
- University of Iowa Hospitals of Clinics, Iowa City, Iowa, United States
- University of Louisville School of Medicine/ Norton Charities Pediatric Clinical Research Unit, Louisville, Kentucky, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- University of Minnesota; Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Children's Hospital at Montefiore/ Albert Einstein University Hospital, The Bronx, New York, United States
- University of North Carolina, Chapel Hill, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- MetroHealth System, Cleveland, Ohio, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- +4 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03841357 on ClinicalTrials.govOther trials for Juvenile idiopathic arthritis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE3NCT07386587Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic ArthritisUniversity of Child Health Sciences and Children's Hospital, Lahore
- RECRUITINGPHASE3NCT06654882Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisDuke University
- RECRUITINGNCT07243782Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in KoreaNovartis Pharmaceuticals
- RECRUITINGNANCT07217782Pain in Juvenile ArthritisWashington University School of Medicine
- RECRUITINGNCT07185750Investigation of Catastrophizing of Pain Reported by Parents in JIA PatientsHacettepe University
- RECRUITINGNCT06806774Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic ArthritisHacettepe University
- RECRUITINGNANCT07234747Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic ArthritisIstanbul University - Cerrahpasa
- RECRUITINGNANCT06474546Feasibility of a Diet Intervention for Juvenile ArthritisThe Hospital for Sick Children